Financial reports
10-K
2023 FY
Annual report
29 Mar 24
10-Q
2023 Q3
Quarterly report
14 Nov 23
10-Q
2023 Q2
Quarterly report
14 Aug 23
ARS
2022 FY
Annual report to shareholders
17 May 23
10-Q
2023 Q1
Quarterly report
15 May 23
10-K
2022 FY
Annual report
7 Apr 23
NT 10-K
Notice of late annual filing
31 Mar 23
10-Q
2022 Q3
Quarterly report
14 Nov 22
10-Q
2022 Q2
Quarterly report
15 Aug 22
Current reports
8-K
TherapeuticsMD Announces Full Year 2023 Financial Results
29 Mar 24
8-K
TherapeuticsMD Announces Third Quarter 2023 Financial Results
14 Nov 23
8-K
Entry into a Material Definitive Agreement
18 Aug 23
8-K
TherapeuticsMD Announces Second Quarter 2023 Financial Results
14 Aug 23
8-K
Changes in Registrant's Certifying Accountant
10 Jul 23
8-K
Unregistered Sales of Equity Securities
6 Jul 23
8-K
Submission of Matters to a Vote of Security Holders
28 Jun 23
8-K
TherapeuticsMD Announces First Quarter 2023 Financial Results
15 May 23
8-K
Entry into a Material Definitive Agreement
5 May 23
8-K
Other Events
21 Apr 23
Registration and prospectus
D
Exempt offering of security
10 Jul 23
D
$7.00 mm in equity / options / securities to be acquired, sold $7.00 mm, 6 investors
14 Nov 22
D
$7.00 mm in equity / options / securities to be acquired, sold $7.00 mm, 6 investors
17 Oct 22
D
$15M in equity / options / securities to be acquired, sold $15M, 6 investors
15 Aug 22
SC 14D9/A
Tender offer solicitation (amended)
13 Jul 22
SC TO-T/A
Third party tender offer statement (amended)
13 Jul 22
SC 14D9/A
Tender offer solicitation (amended)
6 Jul 22
SC TO-T/A
Third party tender offer statement (amended)
6 Jul 22
SC 14D9/A
Tender offer solicitation (amended)
28 Jun 22
SC TO-T/A
Third party tender offer statement (amended)
23 Jun 22
Proxies
DEFA14A
Additional proxy soliciting materials
17 May 23
DEF 14A
Definitive proxy
17 May 23
PRE 14A
Preliminary proxy
1 May 23
DEFA14A
Additional proxy soliciting materials
21 May 21
DEFA14A
Additional proxy soliciting materials
14 Apr 21
DEF 14A
Definitive proxy
14 Apr 21
PRE 14A
Preliminary proxy
1 Apr 21
DEFA14A
Additional proxy soliciting materials
4 May 20
DEF 14A
Definitive proxy
4 May 20
PRER14A
Preliminary revised proxy
22 Apr 20
Other
SEC STAFF
SEC staff action: Order
19 Apr 21
SEC STAFF
SEC staff action: Order
22 Mar 21
EFFECT
Notice of effectiveness
6 May 20
SEC STAFF
SEC staff action: Order
5 Mar 20
SEC STAFF
SEC staff action: Order
4 Feb 20
CT ORDER
Confidential treatment order
10 Apr 19
CT ORDER
Confidential treatment order
12 Dec 18
CT ORDER
Confidential treatment order
21 Aug 18
UPLOAD
Letter from SEC
6 Feb 17
CORRESP
Correspondence with SEC
31 Jan 17
Ownership
4
Marlan D Walker
7 Dec 23
144
Notice of proposed sale of securities
6 Dec 23
SC 13D/A
Rubric Capital Management LP
17 Nov 23
4
David Efraim Rosen
17 Nov 23
4
JOSEPH ZIEGLER
21 Aug 23
3
JOSEPH ZIEGLER
21 Aug 23
4
Tommy G Thompson
19 Jul 23
4
Gail K Naughton
19 Jul 23
4
Cooper C. Collins
19 Jul 23
SC 13D/A
Rubric Capital Management LP
30 Jun 23